HUP0402242A2 - 4-Oxo-butánsav-származékok gyulladás kezelésében történő alkalmazása - Google Patents

4-Oxo-butánsav-származékok gyulladás kezelésében történő alkalmazása

Info

Publication number
HUP0402242A2
HUP0402242A2 HU0402242A HUP0402242A HUP0402242A2 HU P0402242 A2 HUP0402242 A2 HU P0402242A2 HU 0402242 A HU0402242 A HU 0402242A HU P0402242 A HUP0402242 A HU P0402242A HU P0402242 A2 HUP0402242 A2 HU P0402242A2
Authority
HU
Hungary
Prior art keywords
inflammation
treatment
carbon atoms
group containing
acid derivatives
Prior art date
Application number
HU0402242A
Other languages
English (en)
Inventor
Gérard Moinet
Dominique Marais
Philippe Maizeray
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of HUP0402242A2 publication Critical patent/HUP0402242A2/hu
Publication of HUP0402242A3 publication Critical patent/HUP0402242A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A találmány tárgya legalább egy (I) általános képletű 4-oxo-butánsavszármazék alkalmazása gyulladás kezelésére szolgáló gyógyszerelőállítására, ahol a (I) általános képletű vegyület a következőkközül meghatározott: ahol a képletben az A és B csoportok jelentéseegymástól függetlenül - egy mono-, bi- vagy triciklusos arilcsoport,amely 6-14 szénatomot tartalmaz; - egy heteroaromás csoport piridil-,pirimidil-, pirrolil-, furil- vagy tienilcsoportok közül választva; -egy alkilcsoport, amely 1-14 szénatomot tartalmaz; - egycikloalkilcsoport, amely 5-8 szénatomot tartalmaz; - egy telítettheterociklusos csoport tetrahidro-furil-, tetrahidro-piranil-,piperidil- vagy pirrolidinilcsoportok közül választva; ahol az A és Bcsoportok 1-3 szubsztituenst hordozhatnak. Ó
HU0402242A 2001-12-03 2002-11-06 Use of 4-oxobutanoic acid derivatives in the treatment of inflammation HUP0402242A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0115601A FR2832925B1 (fr) 2001-12-03 2001-12-03 Utilisation de derives de l'acide 4-oxobutanoique dans le traitement de l'inflammation
PCT/EP2002/012357 WO2003047561A1 (en) 2001-12-03 2002-11-06 Use of 4-oxobutanoic acid derivatives in the treatment of inflammation

Publications (2)

Publication Number Publication Date
HUP0402242A2 true HUP0402242A2 (hu) 2005-02-28
HUP0402242A3 HUP0402242A3 (en) 2006-01-30

Family

ID=8870049

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0402242A HUP0402242A3 (en) 2001-12-03 2002-11-06 Use of 4-oxobutanoic acid derivatives in the treatment of inflammation

Country Status (19)

Country Link
US (1) US7897644B2 (hu)
EP (1) EP1450780B1 (hu)
JP (1) JP2005511654A (hu)
KR (1) KR20050043728A (hu)
CN (1) CN1599604A (hu)
AT (1) ATE355834T1 (hu)
AU (1) AU2002342883B2 (hu)
BR (1) BR0214644A (hu)
CA (1) CA2468910C (hu)
DE (1) DE60218726T2 (hu)
ES (1) ES2280589T3 (hu)
FR (1) FR2832925B1 (hu)
HU (1) HUP0402242A3 (hu)
MX (1) MXPA04005265A (hu)
PL (1) PL369845A1 (hu)
RU (1) RU2004120557A (hu)
TW (1) TW200300670A (hu)
WO (1) WO2003047561A1 (hu)
ZA (1) ZA200405246B (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008333635A1 (en) * 2007-12-03 2009-06-11 Merck Patent Gmbh Use of 4-oxobutanoic acid derivatives in the treatment of pathologies associated with immunological disorders

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3784701A (en) * 1970-09-21 1974-01-08 American Cyanamid Co Compositions containing substituted benzoylpropionic acids and method of use to treat inflammation and pain
JPS59144717A (ja) * 1983-02-07 1984-08-18 Microbial Chem Res Found 鎮痛剤
US5789434A (en) * 1994-11-15 1998-08-04 Bayer Corporation Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors
GB9522615D0 (en) * 1995-11-03 1996-01-03 Pharmacia Spa 4-Phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity
CO5011113A1 (es) * 1996-05-15 2001-02-28 Bayer Corp Derivados de acido 3-arilbutirico sustituido como inhibidores de la metaloproteasa de matriz y composiciones farmaceuticas que los contienen
FR2752422B1 (fr) * 1996-08-16 1998-11-06 Lipha Composition pharmaceutique contenant des acides 4-oxo-butanoiques
FR2777566B1 (fr) * 1998-04-15 2003-02-21 Synthelabo Derives d'azacycloalcanes, leur preparation et leur application en therapeutique
US6060250A (en) * 1998-06-30 2000-05-09 Incyte Pharmaceuticals, Inc. Human transferases
WO2000006560A1 (en) * 1998-07-30 2000-02-10 Warner-Lambert Company Tricyclic heteroaromatics and their derivatives as inhibitors of matrix metalloproteinases
FR2793411B1 (fr) * 1999-05-11 2001-06-29 Synthelabo Utilisation de derives de l'acide succinique pour obtenir un medicament destine au traitement de l'inflammation
CA2401356A1 (en) * 2000-02-24 2001-08-30 Takeda Chemical Industries, Ltd. Combination drug

Also Published As

Publication number Publication date
EP1450780A1 (en) 2004-09-01
ATE355834T1 (de) 2007-03-15
EP1450780B1 (en) 2007-03-07
FR2832925A1 (fr) 2003-06-06
ES2280589T3 (es) 2007-09-16
TW200300670A (en) 2003-06-16
US7897644B2 (en) 2011-03-01
BR0214644A (pt) 2004-11-03
RU2004120557A (ru) 2005-05-10
FR2832925B1 (fr) 2006-07-14
CA2468910C (en) 2012-01-03
DE60218726D1 (de) 2007-04-19
ZA200405246B (en) 2005-06-24
PL369845A1 (en) 2005-05-02
MXPA04005265A (es) 2004-10-11
US20050014768A1 (en) 2005-01-20
KR20050043728A (ko) 2005-05-11
JP2005511654A (ja) 2005-04-28
AU2002342883A1 (en) 2003-06-17
CA2468910A1 (en) 2003-06-12
CN1599604A (zh) 2005-03-23
HUP0402242A3 (en) 2006-01-30
DE60218726T2 (de) 2007-11-15
AU2002342883B2 (en) 2007-11-29
WO2003047561A1 (en) 2003-06-12

Similar Documents

Publication Publication Date Title
DE69501947D1 (de) SUBSTITUIERTE AROMATISCHE VERBINDUNGEN ALS c. AMP PHOSPHODIESTERASE-UND TNF-HEMMER
BR9812218A (pt) Novos derivativos de taxane
NO20080139L (no) Purinderivater og anvendelse derav som legemiddel
DK1136474T3 (da) 1-Acetyl-5-brom-4,6-dimethylindolin
PT655996E (pt) Benzilaminas substituidas contendo heterociclicos nao aromaticos contendo azoto
HUP9904221A2 (hu) Ciklooxigenáz-2 inhibitorok alkalmazása neoplázia kezelésére és megelőzésére alkalmas gyógyszerkészítmények előállítására
DE69519921T2 (de) Imidazolidin-derivate und ihre verwendung
EA200000731A1 (ru) Альфа-аминоамидные производные, полезные в качестве анальгетических агентов
CA2140441A1 (en) Inhibitors of c-amp phosphodiesterase and tnf
NO20061793L (no) 1,4-disubstituerte isoquinilonderlvater som RAF-kinaseinhibitorer nyttige for behandling av proliferative sykdommer
AU8816298A (en) Oxindolylquinazoline derivatives as angiogenesis inhibitors
HUP0003250A1 (hu) Káliumcsatorna gátló hatású indánszármazékok és az ezeket tartalmazó gyógyszerkészítmények
EP0343900A3 (en) Piperazine compounds
MXPA05008568A (es) Nuevos compuestos anti-inflamatorios triazolo-piridinas.
HUP0301341A2 (hu) CCR-3 inhibitor hatású piperidinszármazékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
ES8302671A1 (es) "procedimiento de preparacion de nuevos derivados 3,4-dihidro-5h-2,3-benzodiazepinos y de sus sales de adicion acidas farmaceuticamente aceptables".
HUP9900851A2 (hu) Benzotiofénszármazékok felhasználása véredény simaizom sejtek migrálásának inhibiálására alkalmas gyógyszerkészítmények előállítására
EP0882714A4 (en) SUBSTITUTED VINYLPYRIDINE DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING THEM
DE3660286D1 (en) Arylcyclobutylalkyl amines and their use as antidepressive medicines
NO306992B1 (no) Quinolinderivater, farmasoeytiske preparater inneholdende forbindelsene og anvendelsen av forbindelsene
ES8506629A1 (es) Un procedimiento para preparar derivados de piridina
GEP20053617B (en) Bridged Piperazine Derivatives
HUP0300402A2 (hu) [Kinolil-(4-piperidinilidén)-metil]-benzamid-származékok fájdalom kezelésére és ezeket tartalmazó gyógyszerkészítmények
HUP0402242A2 (hu) 4-Oxo-butánsav-származékok gyulladás kezelésében történő alkalmazása
EA200000389A3 (ru) Новые замещенные пиридины или пиперидины, способ их получения и содержащие их фармацевтические композиции

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished